United States
MariTide
- Studies
- 23
- Listed
- 568
- Recruiting
- 340
Public compound-country evidence dataPeptides by country.
Peptides by country.
1,722 status checks.
Check whether a named peptide is an approved medicine, an investigational program, or a research-market identity in one destination. Every route connects identity, local context, and the official product and seller records needed to verify the claim.
A source-routing dataset, not a legal or availability verdict.Each row preserves the exact research, clinical-pipeline, or medicine identity and points to the destination records. It does not certify a product, seller, shipment, medical use, safety claim, or country-wide legal status.
Fast exact-record lookup
Find one peptide and country.
Skip the full ledger when you have a specific question. Choose one tracked identity and one destination to open the canonical guide with its three separate official checks.
Exact canonical record
Retatrutide in United States
Investigational clinical program. The country guide keeps that identity separate from the destination product record and the seller or supply record.
- Evidence lane
- Clinical pipeline profile
- Destination
- United States
- Verification path
- Identity → product → seller
Exact-record API / Public JSON
One stable row, without downloading 1,722.
Request a compound slug and country slug to retrieve the same dated record used by the HTML guide and bulk datasets. The response keeps its stable ID, evidence limit, official source routes, canonical guide, license, and current clinical-trial fields attached.
Current public release2026-07-24
Every HTML route, CSV row, and JSON object comes from the same maintained release. Exact status evidence remains separately counted from source-routing rows.
- Compound-country rows
- 1,722
- Tracked names
- 41
- Countries
- 42
- Trial-tracked rows
- 546
- Rows with studies
- 237
- Rows recruiting
- 150
ClinicalTrials.gov country atlas
13 programs. 42 destinations. Exact study footprints.
The July 21, 2026 snapshot joins each tracked intervention to the countries and facilities listed in its official study records. It separates a study-country match from a location individually marked Recruiting.
- Tracked program-country rows
- 546
- Rows with study records
- 237
- Rows with recruiting sites
- 150
- Study-country matches
- 1,237
- Listed locations
- 15,509
- Recruiting locations
- 4,583
United States
Eloralintide
- Studies
- 16
- Listed
- 443
- Recruiting
- 322
United States
Survodutide
- Studies
- 11
- Listed
- 626
- Recruiting
- 251
United States
Amycretin / Zenagamtide
- Studies
- 15
- Listed
- 462
- Recruiting
- 237
United States
Retatrutide
- Studies
- 26
- Listed
- 825
- Recruiting
- 134
United States
Cagrilintide
- Studies
- 36
- Listed
- 1072
- Recruiting
- 118
Interpretation limit: a listed location does not establish approval, public availability, participant eligibility, enrollment, or seller authenticity. A zero is a dated search result, not proof that no study can appear later.
Current decision records
Start with a concrete question.
These paths connect a current approval, trial, or country-access question to the exact identity and official records needed to check it.
Direct answers from live records
Three searches, three different status checks.
These examples show why a country, clinical phase, and approved indication must stay attached to the exact record that supports them.
Mazdutide / China
Where is Mazdutide approved?
China approved specific mazdutide products for chronic weight management and glycemic control in adults with type 2 diabetes. That status does not transfer to the United States or another country.
Eloralintide / worldwide
Is Eloralintide approved?
No. Five ENLIGHTEN Phase 3 records are recruiting, including ENLIGHTEN-6 for persistent obesity during weekly incretin treatment, but they do not establish an approved medicine, pharmacy product, price, or authenticated seller.
Retatrutide / UAE
Can you buy Retatrutide in the UAE?
The July 21 ClinicalTrials.gov snapshot contains no Retatrutide study record with a listed UAE location. That dated zero does not establish approval or availability. Check the UAE product directory and seller authority separately.
What makes this data useful
The joins most global guides leave out.
Every row ties the searched name to a known identity, a destination, the local-language answer, and both sides of the official verification route.
Identity is resolved first
BPC-157 research listings, investigational programs such as retatrutide, and an approved medicine identity such as tirzepatide remain in separate evidence lanes.
Country records stay distinct
The product record and seller or supply record are both attached. A match in one does not automatically prove authorization, seller authority, or current availability in the other.
Every row is reusable
Use the HTML ledger for inspection, CSV for analysis, or JSON for applications. Stable record IDs and canonical guide URLs keep the source trail intact.
Download the release
1722 rows. Evidence depth disclosed.
41 compound partitions
Jump directly into the ledger.
Each partition contains 42 country rows across the same five regional groups. Open one focused ledger at a time, or use its complete world guide.
KPV
Compare KPV across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
BPC-157
Compare BPC-157 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
TB-500
Compare TB-500 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
GHK-Cu
Compare GHK-Cu across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Semax
Compare Semax across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Melanotan II
Compare Melanotan II across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
MOTS-c
Compare MOTS-c across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Tesamorelin
Compare Tesamorelin across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
AOD-9604
Compare AOD-9604 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Ipamorelin
Compare Ipamorelin across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Selank
Compare Selank across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
PT-141 / Bremelanotide
Compare PT-141 / Bremelanotide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
CJC-1295 no DAC
Compare CJC-1295 no DAC across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
CJC-1295 DAC
Compare CJC-1295 DAC across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Retatrutide
Compare Retatrutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Mazdutide
Compare Mazdutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Ecnoglutide
Compare Ecnoglutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Enicepatide
Compare Enicepatide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Eloralintide
Compare Eloralintide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Cagrilintide
Compare Cagrilintide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Petrelintide
Compare Petrelintide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
CagriSema
Compare CagriSema across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
MariTide
Compare MariTide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Survodutide
Compare Survodutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
VK2735
Compare VK2735 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Pemvidutide
Compare Pemvidutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Amycretin / Zenagamtide
Compare Amycretin / Zenagamtide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Tirzepatide
Compare Tirzepatide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Orforglipron / Foundayo
Compare Orforglipron / Foundayo across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Semaglutide
Compare Semaglutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
DSIP / Emideltide
Compare DSIP / Emideltide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
IGF-1 LR3
Compare IGF-1 LR3 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Kisspeptin-10 / KP-10
Compare Kisspeptin-10 / KP-10 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Melanotan I
Compare Melanotan I across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
NAD+
Compare NAD+ across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Sermorelin
Compare Sermorelin across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Thymosin Alpha-1
Compare Thymosin Alpha-1 across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
EGRIFTA WR
Compare EGRIFTA WR across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Liraglutide
Compare Liraglutide across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
SCENESSE
Compare SCENESSE across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
VYLEESI
Compare VYLEESI across 42 countries and five regions. Open official product, pharmacy, seller, and supply records with localized country guidance.
Showing 42 of 1722 rows. The complete release remains available in CSV and JSON.
IGF-1 LR3 / 42 countries
IGF-1 LR3 country records.
This record resolves a name to the US laboratory research catalog tracked by Peptide Local. It does not establish authorization, lawful supply, medical use, or availability in the selected destination. Open the complete world guide →
| Country / region | Localized query and answer | Identity lane | Clinical trials in country | Official destination records | Guide routes | Reviewed |
|---|---|---|---|---|---|---|
| FranceEurope / Français | IGF-1 LR3 en FranceIGF-1 LR3 est suivi comme identité du marché américain de la recherche, et non comme preuve d’autorisation ou d’approvisionnement local en France. Vérifiez la catégorie exacte, l’identité juridique du vendeur et le circuit revendiqué dans les registres officiels de cette page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordBase de données publique des médicamentsMinistère de la Santé ↗Seller or supply recordAlerte sur les peptides vendus en ligneANSM ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| United KingdomEurope / English | IGF-1 LR3 in the United KingdomIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for the United Kingdom. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordSearch licensed medicine product informationMedicines and Healthcare products Regulatory Agency ↗Seller or supply recordSearch the registerGeneral Pharmaceutical Council ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| DeutschlandEurope / Deutsch | IGF-1 LR3 in DeutschlandIGF-1 LR3 wird als Identität im US-Forschungsmarkt geführt, nicht als Nachweis einer Zulassung oder lokalen Versorgung in Deutschland. Prüfe die genaue Kategorie, die rechtliche Anbieteridentität und den behaupteten Bezugsweg in den amtlichen Registern dieser Seite. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordArzneimittelinformationenBundesinstitut für Arzneimittel und Medizinprodukte ↗Seller or supply recordVersandhandels-RegisterBundesinstitut für Arzneimittel und Medizinprodukte ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| EspañaEurope / Español | IGF-1 LR3 en EspañaIGF-1 LR3 se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en España. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordCIMA: Centro de Información online de MedicamentosAgencia Española de Medicamentos y Productos Sanitarios ↗Seller or supply recordDistafarmaAgencia Española de Medicamentos y Productos Sanitarios ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ItaliaEurope / Italiano | IGF-1 LR3 in ItaliaIGF-1 LR3 è seguito come identità del mercato di ricerca statunitense, non come prova di autorizzazione o fornitura locale in Italia. Confronta categoria esatta, identità giuridica del venditore e canale dichiarato con i registri ufficiali di questa pagina. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordBanca dati AIFA MedicinaliAgenzia Italiana del Farmaco ↗Seller or supply recordVenditori online di medicinali autorizzatiMinistero della Salute ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| NederlandEurope / Nederlands | IGF-1 LR3 in NederlandIGF-1 LR3 wordt gevolgd als identiteit op de Amerikaanse onderzoeksmarkt, niet als bewijs van toelating of lokale levering in Nederland. Controleer de exacte categorie, juridische identiteit van de aanbieder en opgegeven route in de officiële registers op deze pagina. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordGeneesmiddeleninformatiebankCollege ter Beoordeling van Geneesmiddelen ↗Seller or supply recordOnline aanbieder van medicijnen controlerenRijksoverheid ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| SwitzerlandEurope / English | IGF-1 LR3 in SwitzerlandIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Switzerland. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordLists of authorized medicinal productsSwissmedic ↗Seller or supply recordGuideline on medicines and the InternetSwissmedic ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| PolskaEurope / Polski | IGF-1 LR3 w PolsceIGF-1 LR3 jest tu identyfikatorem z amerykańskiego rynku badawczego, a nie dowodem dopuszczenia lub lokalnej dostawy w Polsce. Sprawdź dokładną kategorię, prawną tożsamość sprzedawcy i deklarowaną drogę w urzędowych rejestrach na tej stronie. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordRejestr Produktów LeczniczychUrząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych ↗Seller or supply recordSprzedaż leków w InternecieGłówny Inspektorat Farmaceutyczny ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| IrelandEurope / English | IGF-1 LR3 in IrelandIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Ireland. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordFind a medicine for human useHealth Products Regulatory Authority ↗Seller or supply recordPSI public registersPharmaceutical Society of Ireland ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| PortugalEurope / Português (Portugal) | IGF-1 LR3 em PortugalIGF-1 LR3 é acompanhado como identidade do mercado de investigação dos EUA, não como prova de autorização ou fornecimento local em Portugal. Compare a categoria exata, a identidade jurídica do vendedor e a via alegada com os registos oficiais desta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordBase de dados nacional de medicamentos InfomedINFARMED ↗Seller or supply recordLista pública de farmácias licenciadasINFARMED ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| SverigeEurope / Svenska | IGF-1 LR3 i SverigeIGF-1 LR3 följs som en identitet på den amerikanska forskningsmarknaden, inte som bevis på godkännande eller lokal leverans i Sverige. Kontrollera exakt kategori, säljarens juridiska identitet och den påstådda vägen i de officiella registren på sidan. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordNationellt produktregister för läkemedelLäkemedelsverket ↗Seller or supply recordSök apotek som har tillståndLäkemedelsverket ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| TürkiyeEurope / Türkçe | Türkiye için IGF-1 LR3IGF-1 LR3, ABD araştırma pazarında kullanılan bir kimlik olarak izlenir; Türkiye için ruhsat, yasal tedarik veya gerçek bulunabilirlik kanıtı değildir. Ürün sınıfını, satıcının hukuki kimliğini, güncel faaliyet durumunu ve iddia edilen tedarik yolunu bu sayfadaki resmi ürün ve kuruluş kayıtlarında ayrı ayrı eşleştirin. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordRuhsatlı Ürünler ListesiTürkiye İlaç ve Tıbbi Cihaz Kurumu ↗Seller or supply recordRuhsatlı Ecza TicarethaneleriTürkiye İlaç ve Tıbbi Cihaz Kurumu ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ÖsterreichEurope / Deutsch | IGF-1 LR3 in ÖsterreichIGF-1 LR3 wird als Identität im US-Forschungsmarkt geführt, nicht als Nachweis einer Zulassung oder lokalen Versorgung in Österreich. Prüfe die genaue Kategorie, die rechtliche Anbieteridentität und den behaupteten Bezugsweg in den amtlichen Registern dieser Seite. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordArzneispezialitätenregisterBundesamt für Sicherheit im Gesundheitswesen ↗Seller or supply recordÖffentliche Register für Arzneimittelbetriebe und VersandapothekenBundesamt für Sicherheit im Gesundheitswesen ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| BelgiëEurope / Nederlands | IGF-1 LR3 in BelgiëIGF-1 LR3 wordt gevolgd als identiteit op de Amerikaanse onderzoeksmarkt, niet als bewijs van toelating of lokale levering in België. Controleer de exacte categorie, juridische identiteit van de aanbieder en opgegeven route in de officiële registers op deze pagina. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordDatabank van geneesmiddelen met geldige vergunningenFederaal Agentschap voor Geneesmiddelen en Gezondheidsproducten ↗Seller or supply recordOfficiële route voor internetapothekenFederaal Agentschap voor Geneesmiddelen en Gezondheidsproducten ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| DanmarkEurope / Dansk | IGF-1 LR3 i DanmarkIGF-1 LR3 følges som en identitet på det amerikanske forskningsmarked, ikke som dokumentation for godkendelse, lovlig forsyning eller faktisk tilgængelighed i Danmark. Sammenhold produktkategori, sælgerens juridiske identitet, aktuel registerstatus og den påståede forsyningsvej med de separate officielle registre på denne side. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordLister med oplysninger om lægemidlerLægemiddelstyrelsen ↗Seller or supply recordApoteker der lovligt sælger medicin på nettetLægemiddelstyrelsen ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| SuomiEurope / Suomi | IGF-1 LR3 kohteessa SuomiIGF-1 LR3 seurataan Yhdysvaltain tutkimusmarkkinassa käytettynä identiteettinä, ei todisteena hyväksynnästä, laillisesta toimituksesta tai todellisesta saatavuudesta kohteessa Suomi. Vertaa tuoteluokka, myyjän oikeudellinen identiteetti, nykyinen rekisteritila ja väitetty toimitusreitti erikseen tämän sivun virallisiin rekistereihin. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordFimean lääkehaku ja myyntiluvalliset lääkkeet SuomessaLääkealan turvallisuus- ja kehittämiskeskus Fimea ↗Seller or supply recordLuettelo laillisista apteekin verkkopalveluistaLääkealan turvallisuus- ja kehittämiskeskus Fimea ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| MéxicoLatin America / Español | IGF-1 LR3 en MéxicoIGF-1 LR3 se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en México. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordVisor de registros de medicamentosCOFEPRIS ↗Seller or supply recordDistribuidores irregularesCOFEPRIS ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ArgentinaLatin America / Español | IGF-1 LR3 en ArgentinaIGF-1 LR3 se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Argentina. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordMedicamentos, registro y Vademécum NacionalAdministración Nacional de Medicamentos, Alimentos y Tecnología Médica ↗Seller or supply recordDroguerías y establecimientos habilitadosAdministración Nacional de Medicamentos, Alimentos y Tecnología Médica ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ColombiaLatin America / Español | IGF-1 LR3 en ColombiaIGF-1 LR3 se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Colombia. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordConsulta de registros sanitariosInstituto Nacional de Vigilancia de Medicamentos y Alimentos ↗Seller or supply recordEstablecimientos nacionales de medicamentos certificadosInstituto Nacional de Vigilancia de Medicamentos y Alimentos ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ChileLatin America / Español | IGF-1 LR3 en ChileIGF-1 LR3 se registra como identidad del mercado estadounidense de investigación, no como prueba de autorización o suministro local en Chile. Contrasta la categoría exacta, la identidad legal del vendedor y la vía declarada con los registros oficiales de esta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordRegistro sanitario de productos farmacéuticosInstituto de Salud Pública de Chile ↗Seller or supply recordFarmacias y listados de autorizacionesInstituto de Salud Pública de Chile ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| BrasilLatin America / Português (Brasil) | IGF-1 LR3 no BrasilIGF-1 LR3 é acompanhado como identidade do mercado de pesquisa dos EUA, não como prova de autorização ou fornecimento local no Brasil. Compare a categoria exata, a identidade jurídica do vendedor e a rota alegada com os registros oficiais desta página. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordConsulta a registro de medicamentosAgência Nacional de Vigilância Sanitária ↗Seller or supply recordConsulta de drogarias e farmáciasAgência Nacional de Vigilância Sanitária ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| 中国Asia-Pacific / 简体中文 | IGF-1 LR3 在中国的状态与官方记录IGF-1 LR3在此仅作为美国科研市场中的名称身份跟踪，并不是其在中国获批、合法供应或实际可得的证明。必须通过本页链接的官方记录，分别核对具体类别、产品信息、法律经营主体、登记状态与声称的供应路径，不能让科研标签继承药品批准或临床项目证据。 | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product record国家药品监督管理局数据查询国家药品监督管理局 ↗Seller or supply record国家企业信用信息公示系统国家市场监督管理总局 ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| AustraliaAsia-Pacific / English | IGF-1 LR3 in AustraliaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Australia. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordSearching the Australian Register of Therapeutic GoodsTherapeutic Goods Administration ↗Seller or supply recordPersonal Importation SchemeTherapeutic Goods Administration ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| New ZealandAsia-Pacific / English | IGF-1 LR3 in New ZealandIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for New Zealand. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordUnapproved peptide products health warningNew Zealand Medicines and Medical Devices Safety Authority ↗Seller or supply recordProduct and application searchNew Zealand Medicines and Medical Devices Safety Authority ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| IndiaAsia-Pacific / English | IGF-1 LR3 in IndiaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for India. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordApproved new drugsCentral Drugs Standard Control Organization ↗Seller or supply recordDrug and quality alertsCentral Drugs Standard Control Organization ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| 日本Asia-Pacific / 日本語 | 日本のIGF-1 LR3IGF-1 LR3は米国の研究市場で使われる名称として追跡しており、日本での承認、合法な供給、実際の入手可能性を示すものではありません。このページの公的記録で、製品区分、販売主体の法的名称、現在の登録状態、主張される供給経路を個別に照合してください。 | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product record承認品目情報独立行政法人医薬品医療機器総合機構（PMDA） ↗Seller or supply record製品、安全性、電子添文、審査情報の検索入口独立行政法人医薬品医療機器総合機構（PMDA） ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| 대한민국Asia-Pacific / 한국어 | 대한민국의 IGF-1 LR3IGF-1 LR3은 미국 연구 시장에서 사용되는 명칭으로 추적되며, 대한민국에서의 허가, 합법적 공급 또는 실제 이용 가능성을 의미하지 않습니다. 이 페이지의 공식 기록에서 정확한 제품 유형, 판매 주체의 법적 신원, 현재 등록 상태와 주장된 공급 경로를 각각 대조하세요. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product record식품의약품안전처 의약품 품목 허가 정보대한민국 공공데이터포털 ↗Seller or supply record병원·약국 찾기건강보험심사평가원 ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| ประเทศไทยAsia-Pacific / ไทย | IGF-1 LR3 ในประเทศไทยIGF-1 LR3 ถูกติดตามในฐานะชื่อที่ใช้ในตลาดวัสดุวิจัยของสหรัฐฯ ไม่ใช่หลักฐานการอนุมัติ การจัดหาโดยชอบด้วยกฎหมาย หรือความพร้อมขายจริงในประเทศไทย ต้องเทียบประเภทผลิตภัณฑ์ นิติบุคคลของผู้ขาย สถานะทะเบียนปัจจุบัน และเส้นทางการจัดหาที่อ้างกับบันทึกทางการในหน้านี้ | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordระบบค้นหาข้อมูลผลิตภัณฑ์ยาสำนักงานคณะกรรมการอาหารและยา ↗Seller or supply recordระบบค้นหาสถานที่และผู้ดำเนินการด้านยาสำนักงานคณะกรรมการอาหารและยา ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| IndonesiaAsia-Pacific / Bahasa Indonesia | IGF-1 LR3 di IndonesiaIGF-1 LR3 dilacak sebagai identitas yang digunakan di pasar riset Amerika Serikat, bukan sebagai bukti persetujuan, pasokan yang legal, atau ketersediaan nyata di Indonesia. Cocokkan kategori produk, identitas hukum penjual, status catatan terkini, dan jalur pasok yang diklaim dengan catatan resmi di halaman ini. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordPencarian produk terdaftar Cek BPOMBadan Pengawas Obat dan Makanan ↗Seller or supply recordInformasi publik sertifikat dan pencabutan CDOBBadan Pengawas Obat dan Makanan ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| SingaporeAsia-Pacific / English | IGF-1 LR3 in SingaporeIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Singapore. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordHSA InfosearchSingapore Health Sciences Authority ↗Seller or supply recordSupply through e-pharmacySingapore Health Sciences Authority ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| PhilippinesAsia-Pacific / English | IGF-1 LR3 in the PhilippinesIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for the Philippines. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordFDA Verification PortalFood and Drug Administration Philippines ↗Seller or supply recordFDA advisory on Verification Portal useFood and Drug Administration Philippines ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| MalaysiaAsia-Pacific / English | IGF-1 LR3 in MalaysiaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Malaysia. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordQUEST3+ Product SearchNational Pharmaceutical Regulatory Agency ↗Seller or supply recordProduct registration FAQNational Pharmaceutical Regulatory Agency ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| 台灣Asia-Pacific / 繁體中文（台灣） | IGF-1 LR3 在台灣的紀錄IGF-1 LR3在此僅作為美國研究市場名稱追蹤，不能證明其在台灣獲准、合法供應或實際可得。請在本頁官方紀錄中分別核對產品類別、許可證資料、賣方或機構法律身分、目前狀態與宣稱的供應途徑，研究用途標示不能承接藥品許可。 | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product record西藥、醫療器材、特定用途化粧品許可證查詢衛生福利部食品藥物管理署 ↗Seller or supply record醫事機構查詢衛生福利部 ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| 香港Asia-Pacific / 繁體中文（香港） | IGF-1 LR3 在香港的紀錄IGF-1 LR3在此只作為美國研究市場名稱追蹤，不能證明其在香港已註冊、合法供應或實際可得。請在本頁官方紀錄中分別核對產品類別、註冊資料、銷售商法定身分、牌照狀態和聲稱的供應途徑，研究用途標籤不能承接藥劑製品註冊。 | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product record搜尋藥物資料庫香港衞生署藥物辦公室 ↗Seller or supply record搜尋持牌藥物銷售商香港衞生署藥物辦公室 ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| Việt NamAsia-Pacific / Tiếng Việt | IGF-1 LR3 tại Việt NamIGF-1 LR3 được theo dõi như một danh tính trên thị trường nghiên cứu Hoa Kỳ, không phải bằng chứng về giấy phép, nguồn cung hợp pháp hay khả năng có hàng tại Việt Nam. Hãy đối chiếu riêng loại sản phẩm, pháp nhân người bán, tình trạng hồ sơ hiện hành và đường cung ứng được tuyên bố trong các nguồn chính thức trên trang này. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordCông bố giấy đăng ký thuốc và nguyên liệu làm thuốcCục Quản lý Dược, Bộ Y tế ↗Seller or supply recordThông tin cơ sở bán buôn thuốcCục Quản lý Dược, Bộ Y tế ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| United StatesNorth America / English | IGF-1 LR3 in the United StatesIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for the United States. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordDrugs@FDA approved drug databaseU.S. Food and Drug Administration ↗Seller or supply recordLocate a state-licensed online pharmacyU.S. Food and Drug Administration ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| CanadaNorth America / English | IGF-1 LR3 in CanadaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Canada. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordDrug Product DatabaseHealth Canada ↗Seller or supply recordChoosing a safe online pharmacyHealth Canada ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| الإمارات العربية المتحدةMiddle East and Africa / العربية | IGF-1 LR3 في الإمارات العربية المتحدةيتم تتبع IGF-1 LR3 هنا كهوية مستخدمة في سوق الأبحاث الأمريكي، وليس كدليل على الترخيص أو التوريد المحلي في الإمارات العربية المتحدة. يجب مطابقة الفئة المحددة والهوية القانونية للبائع ومسار التوريد المعلن مع سجلات المنتج والمنشأة الرسمية في هذه الصفحة قبل استنتاج التوفر أو المشروعية. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordدليل المنتجات الطبية المسجلة لدى مؤسسة الإمارات للدواءمؤسسة الإمارات للدواء ↗Seller or supply recordترخيص الصيادلةوزارة الصحة ووقاية المجتمع الإماراتية ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| المملكة العربية السعوديةMiddle East and Africa / العربية | IGF-1 LR3 في المملكة العربية السعوديةيتم تتبع IGF-1 LR3 هنا كهوية مستخدمة في سوق الأبحاث الأمريكي، وليس كدليل على الترخيص أو التوريد المحلي في المملكة العربية السعودية. يجب مطابقة الفئة المحددة والهوية القانونية للبائع ومسار التوريد المعلن مع سجلات المنتج والمنشأة الرسمية في هذه الصفحة قبل استنتاج التوفر أو المشروعية. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordقائمة الأدويةالهيئة العامة للغذاء والدواء ↗Seller or supply recordقائمة المنشآت المرخصةالهيئة العامة للغذاء والدواء ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| South AfricaMiddle East and Africa / English | IGF-1 LR3 in South AfricaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for South Africa. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordMedicines Online DirectorySouth African Health Products Regulatory Authority ↗Seller or supply recordPharmaceutical establishment licensingSouth African Health Products Regulatory Authority ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| NigeriaMiddle East and Africa / English | IGF-1 LR3 in NigeriaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Nigeria. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordNAFDAC Greenbook registered product databaseNational Agency for Food and Drug Administration and Control ↗Seller or supply recordPharmacist and premises verificationPharmacy Council of Nigeria ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
| KenyaMiddle East and Africa / English | IGF-1 LR3 in KenyaIGF-1 LR3 is tracked as a US research-market identity, not as an authorization or local supply finding for Kenya. Match the exact category, legal seller identity, and claimed route against the official records on this page. | Research price boardUS research-market identityidentity plus country routes / 0 exact status sourcesIdentity source ↗ | Outside current 13-program snapshot This is not evidence that no study exists. | Product recordPublic pharmaceutical products registerKenya Pharmacy and Poisons Board ↗Seller or supply recordPublic facilities licence registerKenya Pharmacy and Poisons Board ↗ | Exact guide →Country guide →World guide →Exact checker ↗ | 2026-07-24 |
Data dictionary
Stable fields, bounded meaning.
The page, CSV, and JSON are generated from the same maintained records. The definitions prevent an identity match or official link from being mistaken for a legal, quality, availability, or seller-verification conclusion.
- recordId
- Stable Peptide Local identifier for one compound and destination-country verification row.
- compound
- Resolved compound or medicine identity used by the linked Peptide Local evidence record.
- evidenceLane
- Research price board, clinical pipeline profile, or approved medicine record. These lanes are not interchangeable.
- country
- Destination jurisdiction whose official product and seller or supply records are linked.
- region
- One of five geographic discovery groups. The country record remains the verification boundary.
- contentLanguage
- Language used for the localized query and bounded country answer.
- localizedQuery
- Country-language heading for the compound and destination combination.
- localizedAnswer
- Editorial routing answer that preserves the identity lane and states which local claims remain unverified.
- statusSpecificity
- Evidence-depth label distinguishing a sourced compound-country status, a country-specific editorial status without a separate exact source URL, and an identity record joined only to general country verification routes.
- statusEvidenceBasis
- Plain-language boundary explaining what the row's evidence depth can and cannot establish.
- statusEvidenceSourceCount
- Number of compound and destination-specific source URLs attached to the status summary. This excludes the separate identity, product, and seller or supply routes.
- statusEvidencePublishers
- Publishers of the compound and destination-specific status sources, when present.
- statusEvidenceUrls
- Compound and destination-specific source URLs supporting the status summary, when present.
- clinicalTrialScope
- Whether the compound is included in the current thirteen-program ClinicalTrials.gov snapshot. Outside scope is not evidence that no study exists.
- clinicalTrialProgramName
- Canonical program name used by the current intervention-search snapshot, when the row is in scope.
- clinicalTrialRegistryCountry
- ClinicalTrials.gov country label used to match listed study locations to the destination row.
- clinicalTrialSnapshotDate
- ISO date of the ClinicalTrials.gov snapshot used for the country-level counts.
- clinicalTrialRecords
- Number of matched study records that list at least one location in the destination country. Zero is a dated search result, not a permanent conclusion.
- clinicalTrialListedLocations
- Sum of listed facility observations in the destination country across the matched study records.
- clinicalTrialRecruitingLocations
- Sum of destination facilities individually marked Recruiting in the registry snapshot.
- clinicalTrialRecordsWithRecruitingLocations
- Number of matched study records with at least one destination facility individually marked Recruiting.
- clinicalTrialRecordIds
- Exact NCT identifiers for all matched country-level study records in the snapshot.
- clinicalTrialRecordUrls
- Direct ClinicalTrials.gov URLs for all matched country-level study records.
- clinicalTrialFinderUrl
- Peptide Local trial finder filtered to the exact program and registry country.
- clinicalTrialRegistrySearchUrl
- Live ClinicalTrials.gov intervention and country search used to recheck the dated snapshot.
- identitySourceUrl
- Primary compound, medicine, or clinical-program identity source.
- productRecordUrl
- Official national product, medicine, or regulatory record used by the country guide.
- sellerOrSupplyRecordUrl
- Official pharmacy, establishment, professional, seller, or supply record used by the country guide.
- canonicalGuideUrl
- Canonical Peptide Local page for this exact compound and destination-country verification record.
- reviewedDate
- ISO date when the published compound-country record and its source route were reviewed.
Citation and method
Keep the landing page with the data.
Suggested citation: Peptide Local Editorial Desk. “Peptide Local Global Compound-by-Country Verification Index.” Version 2026-07-24. https://peptidelocal.com/data/global-peptide-country-index
The dataset is free to inspect and download. Link to this canonical landing page when citing a row so readers retain the definitions, date, evidence boundary, and current source routes.
Read the complete publication method →Read the 2026 global findings report →Browse the complete public data catalog →Audit the site-wide source registry →Request data corrections or press information →